86 related articles for article (PubMed ID: 26194323)
1. Do cardiac actin mutations lead to altered actomyosin interactions?
Dahari M; Dawson JF
Biochem Cell Biol; 2015 Aug; 93(4):330-4. PubMed ID: 26194323
[TBL] [Abstract][Full Text] [Related]
2. Cardiac actin changes in the actomyosin interface have different effects on myosin duty ratio.
Liu H; Henein M; Anillo M; Dawson JF
Biochem Cell Biol; 2018 Feb; 96(1):26-31. PubMed ID: 28972856
[TBL] [Abstract][Full Text] [Related]
3. The immediate effect of HCM causing actin mutants E99K and A230V on actin-Tm-myosin interaction in thin-filament reconstituted myocardium.
Bai F; Caster HM; Dawson JF; Kawai M
J Mol Cell Cardiol; 2015 Feb; 79():123-32. PubMed ID: 25451174
[TBL] [Abstract][Full Text] [Related]
4. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.
Debold EP; Saber W; Cheema Y; Bookwalter CS; Trybus KM; Warshaw DM; Vanburen P
J Mol Cell Cardiol; 2010 Feb; 48(2):286-92. PubMed ID: 19799913
[TBL] [Abstract][Full Text] [Related]
5. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.
Olson TM; Doan TP; Kishimoto NY; Whitby FG; Ackerman MJ; Fananapazir L
J Mol Cell Cardiol; 2000 Sep; 32(9):1687-94. PubMed ID: 10966831
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of a mutation in an expressed human alpha-cardiac actin at a site implicated in familial hypertrophic cardiomyopathy.
Bookwalter CS; Trybus KM
J Biol Chem; 2006 Jun; 281(24):16777-84. PubMed ID: 16611632
[TBL] [Abstract][Full Text] [Related]
7. A Cardiomyopathy Mutation in the Myosin Essential Light Chain Alters Actomyosin Structure.
Guhathakurta P; Prochniewicz E; Roopnarine O; Rohde JA; Thomas DD
Biophys J; 2017 Jul; 113(1):91-100. PubMed ID: 28700929
[TBL] [Abstract][Full Text] [Related]
8. Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.
Chow ML; Shaffer JF; Harris SP; Dawson JF
Arch Biochem Biophys; 2014 May; 550-551():28-32. PubMed ID: 24736382
[TBL] [Abstract][Full Text] [Related]
9. Skeletal and cardiac α-actin isoforms differently modulate myosin cross-bridge formation and myofibre force production.
Ochala J; Iwamoto H; Ravenscroft G; Laing NG; Nowak KJ
Hum Mol Genet; 2013 Nov; 22(21):4398-404. PubMed ID: 23784376
[TBL] [Abstract][Full Text] [Related]
10. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
[TBL] [Abstract][Full Text] [Related]
11. Functional Characterization of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G).
Hassoun R; Erdmann C; Schmitt S; Fujita-Becker S; Mügge A; Schröder RR; Geyer M; Borbor M; Jaquet K; Hamdani N; Mannherz HG
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457283
[TBL] [Abstract][Full Text] [Related]
12. The myosin cardiac loop participates functionally in the actomyosin interaction.
Ajtai K; Garamszegi SP; Watanabe S; Ikebe M; Burghardt TP
J Biol Chem; 2004 May; 279(22):23415-21. PubMed ID: 15020589
[TBL] [Abstract][Full Text] [Related]
13. Myosin dilated cardiomyopathy mutation S532P disrupts actomyosin interactions, leading to altered muscle kinetics, reduced locomotion, and cardiac dilation in
Trujillo AS; Hsu KH; Puthawala J; Viswanathan MC; Loya A; Irving TC; Cammarato A; Swank DM; Bernstein SI
Mol Biol Cell; 2021 Aug; 32(18):1690-1706. PubMed ID: 34081531
[TBL] [Abstract][Full Text] [Related]
14. M-class hypertrophic cardiomyopathy cardiac actin mutations increase calcium sensitivity of regulated thin filaments.
Teng GZ; Shaikh Z; Liu H; Dawson JF
Biochem Biophys Res Commun; 2019 Oct; 519(1):148-152. PubMed ID: 31481237
[TBL] [Abstract][Full Text] [Related]
15. Kinetic characterization of the function of myosin loop 4 in the actin-myosin interaction.
Gyimesi M; Tsaturyan AK; Kellermayer MS; Málnási-Csizmadia A
Biochemistry; 2008 Jan; 47(1):283-91. PubMed ID: 18067324
[TBL] [Abstract][Full Text] [Related]
16. Dilated cardiomyopathy mutation in the converter domain of human cardiac myosin alters motor activity and response to omecamtiv mecarbil.
Tang W; Unrath WC; Desetty R; Yengo CM
J Biol Chem; 2019 Nov; 294(46):17314-17325. PubMed ID: 31578282
[TBL] [Abstract][Full Text] [Related]
17. Functional studies of yeast actin mutants corresponding to human cardiomyopathy mutations.
Wong WW; Doyle TC; Cheung P; Olson TM; Reisler E
J Muscle Res Cell Motil; 2001; 22(8):665-74. PubMed ID: 12222827
[TBL] [Abstract][Full Text] [Related]
18. The effect of genetically expressed cardiac titin fragments on in vitro actin motility.
Li Q; Jin JP; Granzier HL
Biophys J; 1995 Oct; 69(4):1508-18. PubMed ID: 8534821
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.
Song W; Dyer E; Stuckey DJ; Copeland O; Leung MC; Bayliss C; Messer A; Wilkinson R; Tremoleda JL; Schneider MD; Harding SE; Redwood CS; Clarke K; Nowak K; Monserrat L; Wells D; Marston SB
J Biol Chem; 2011 Aug; 286(31):27582-93. PubMed ID: 21622575
[TBL] [Abstract][Full Text] [Related]
20. The effect of the dilated cardiomyopathy-causing Glu40Lys TPM1 mutation on actin-myosin interactions during the ATPase cycle.
Borovikov YS; Avrova SV; Karpicheva OE; Robinson P; Redwood CS
Biochem Biophys Res Commun; 2011 Aug; 411(3):496-500. PubMed ID: 21741356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
